• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[大鼠模型中静脉注射各种免疫球蛋白制剂治疗腹膜炎的有效性]

[Effectiveness of various immunoglobulin preparations administered by the intravenous route in peritonitis in the rat model].

作者信息

Hart H, Seifert J, Brendel W

出版信息

Arzneimittelforschung. 1987 Feb;37(2):170-4.

PMID:3580020
Abstract

Intraabdominal sepsis in rats was induced as a sublethal infection (mortality rate of controls: 60%-80%) and as a lethal infection (mortality rate of controls: 100%). The effectivity of different immunoglobulin (IgG) preparations alone or together with an antibiotic combination therapy (gentamicin + piperacillin) was then tested. In sublethal infection, 5 intravenous administrations of three 7S-IgG preparations and a plasmin-treated preparation at a dosage of 0.5 g/kg b.w. were able to reduce lethality only slightly, whereas a 5S-IgG preparation was able to reduce lethality by 30% significantly. Intraperitoneal administration of two 7S-IgG preparations (s-sulfitolysis, 42 degrees C/ammonium sulfate) and the 5S-IgG preparation reduced lethality to 27%, 37% and 47%, respectively, whereas another 7S-IgG (iodoacetamide/dithiothreitol) and a plasmin-treated preparation failed to reduce lethality significantly. The convincing results obtained with the 5S-IgG preparation are probably due to the fact that Fc-mediated side-effects could be avoided. The better effectivity of intraperitoneal compared to intravenous administration can be explained by much higher concentrations of specific antibodies at the site of infection. In the lethal infection model the mortality of animals treated with antibiotics only was 50%. The additional intravenous administration of 7S-IgG (42 degrees C/ammonium sulfate), a plasmin-treated preparation and a 5S-IgG was unable to reduce mortality any further. These findings are in contrast to several publications which postulate synergism of antibiotics and immunoglobulins.

摘要

在大鼠中诱导腹腔内脓毒症,分别造成亚致死性感染(对照组死亡率:60%-80%)和致死性感染(对照组死亡率:100%)。然后测试不同免疫球蛋白(IgG)制剂单独使用或与抗生素联合治疗(庆大霉素+哌拉西林)的有效性。在亚致死性感染中,以0.5 g/kg体重的剂量静脉注射三种7S-IgG制剂和一种纤溶酶处理的制剂各5次,仅能轻微降低致死率,而一种5S-IgG制剂能显著降低致死率30%。腹腔注射两种7S-IgG制剂(s-亚硫酸解,42℃/硫酸铵)和5S-IgG制剂分别将致死率降至27%、37%和47%,而另一种7S-IgG(碘乙酰胺/二硫苏糖醇)和一种纤溶酶处理的制剂未能显著降低致死率。5S-IgG制剂获得的令人信服的结果可能是由于可以避免Fc介导的副作用。腹腔注射比静脉注射效果更好,可以用感染部位特异性抗体浓度高得多来解释。在致死性感染模型中,仅用抗生素治疗的动物死亡率为50%。额外静脉注射7S-IgG(42℃/硫酸铵)、一种纤溶酶处理的制剂和一种5S-IgG并不能进一步降低死亡率。这些发现与一些假设抗生素和免疫球蛋白具有协同作用的出版物形成对比。

相似文献

1
[Effectiveness of various immunoglobulin preparations administered by the intravenous route in peritonitis in the rat model].[大鼠模型中静脉注射各种免疫球蛋白制剂治疗腹膜炎的有效性]
Arzneimittelforschung. 1987 Feb;37(2):170-4.
2
[Anaphylactic shock reaction following intravenous administration of 7S immunoglobulin in patients with hypogammaglobulinemia, especially in children with acute lymphoblastic leukemia (ALL)].低丙种球蛋白血症患者,尤其是急性淋巴细胞白血病(ALL)患儿静脉注射7S免疫球蛋白后发生的过敏性休克反应
Klin Padiatr. 1987 Jul-Aug;199(4):274-8. doi: 10.1055/s-2008-1026802.
3
Effects of intravenous gamma immunoglobulins treatment on severe peritonitis in rats.静脉注射丙种球蛋白治疗对大鼠重症腹膜炎的影响。
Int J Surg Investig. 2001;2(6):433-42.
4
[Intravenous immunoglobulins in newborn infants at risk of infection. Comparative efficacy of preparations 7S and 5S].[处于感染风险的新生儿静脉注射免疫球蛋白。7S和5S制剂的比较疗效]
Minerva Pediatr. 1990 Jan-Feb;42(1-2):15-8.
5
Comparison of in vitro behaviour and in vivo efficacy of two 7S-immunoglobulin preparations for intravenous use.两种静脉用7S免疫球蛋白制剂的体外行为与体内疗效比较。
Arzneimittelforschung. 1983;33(11):1538-40.
6
Efficaciousness of immunoglobulin G prophylaxis on mortality and physiological variables in gram-negative peritonitis in rodents.免疫球蛋白G预防对啮齿动物革兰氏阴性腹膜炎死亡率和生理变量的有效性。
Circ Shock. 1985;17(3):213-22.
7
Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.鲎素III和粒细胞集落刺激因子可增强他唑巴坦/哌拉西林在中性粒细胞减少的多微生物腹膜炎小鼠模型中的疗效。
Peptides. 2008 Jan;29(1):31-8. doi: 10.1016/j.peptides.2007.10.024. Epub 2007 Nov 6.
8
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.牛抗菌肽吲哚杀菌素与哌拉西林/他唑巴坦联用在大鼠多菌性腹膜炎实验模型中的疗效
Crit Care Med. 2008 Jan;36(1):240-5. doi: 10.1097/01.CCM.0000292157.60632.89.
9
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia.一项针对低丙种球蛋白血症或无丙种球蛋白血症患者的新型10%液体静脉注射免疫球蛋白的药代动力学、疗效和安全性的前瞻性开放标签研究。
Vox Sang. 2006 May;90(4):286-93. doi: 10.1111/j.1423-0410.2006.00764.x.
10
[Immunotherapy with immunoglobulins].[免疫球蛋白免疫疗法]
Zentralbl Gynakol. 1984;106(24):1557-71.